Finanzwire Finanzwire
Basculer en Français
11384 Companies
253058 Keywords
182715 Articles
138802 Press releases
Headlines Articles Press releases Secarna Pharmaceuticals GmbH & Co. KG Remove
  1. Home
  2. Companies
  3. Secarna Pharmaceuticals GmbH & Co. KG
Finanzwire
Basculer en Français
Headlines Articles Press releases

News

  • PRESS RELEASE

    published on 11/03/2023 at 18:05, 3 years ago

    Secarna Pharmaceuticals presents data at SITC demonstrating the potential of antisense oligonucleotides in targeting NRP1

    Logo of Secarna Pharmaceuticals GmbH & Co. KG
  • PRESS RELEASE

    published on 10/25/2023 at 15:00, 3 years ago

    Secarna Pharmaceuticals presents data at OTS showcasing unique characteristics and factors with a role in the activity and side effect profile of LNA-modified ASOs

    Logo of Secarna Pharmaceuticals GmbH & Co. KG
  • PRESS RELEASE

    published on 10/17/2023 at 14:00, 3 years 1 month ago

    Secarna Pharmaceuticals to present two posters showcasing the innovation potential of the LNAplus platform at the 19th Annual Meeting of the Oligonucleotide Therapeutic Society

    Logo of Secarna Pharmaceuticals GmbH & Co. KG
  • PRESS RELEASE

    published on 07/06/2023 at 14:00, 3 years 4 months ago

    Secarna Pharmaceuticals publishes new preclinical data in The Journal of Immunology demonstrating potent therapeutic activity of LNAplus™ ASO targeting NLRP3 in debilitating autoinflammatory diseases

    Logo of Secarna Pharmaceuticals GmbH & Co. KG
  • PRESS RELEASE

    published on 06/05/2023 at 14:00, 3 years 5 months ago

    Secarna Pharmaceuticals announces publication of new preclinical data showing durable antitumor activity of LNAplus™-based ASOs that both stimulate the innate immune system and suppress PD-L1 expressi

    Logo of Secarna Pharmaceuticals GmbH & Co. KG
  • PRESS RELEASE

    published on 03/27/2023 at 16:04, 3 years 7 months ago

    Secarna Pharmaceuticals and SciNeuro Pharmaceuticals enter into research and option agreement in the field of CNS diseases

    Logo of Secarna Pharmaceuticals GmbH & Co. KG
Previous page
1 ... 3 4
Accesswire
  • Published on 11/20/2026 at 15:00, 16 hours 46 minutes ago

    Jaguar Health, Inc. Announces Reverse Stock Split

  • Published on 11/20/2026 at 14:50, 16 hours 56 minutes ago

    Proposed Issue Of Payment-In-Kind Interest Shares Under Convertible Debenture

  • Published on 11/20/2026 at 14:00, 17 hours 46 minutes ago

    Dateline appoints Tony Ferguson as Acting Chairman

  • Published on 11/20/2026 at 13:30, 18 hours 16 minutes ago

    Collective Metals Enters Into Option to Acquire the Lac Tio West Property in Quebec

  • Published on 11/20/2026 at 13:30, 18 hours 16 minutes ago

    Alset AI Closes Non-Brokered Private Placement Offering

View all ACCESSWIRE
EQS Group
  • Published on 11/20/2026 at 23:45, 8 hours ago

    APEC CEO Summit 2026 Concludes Successfully in Shenzhen

  • Published on 11/20/2026 at 22:36, 9 hours 9 minutes ago

    Abivax Statement on Short Seller Report

  • Published on 11/20/2026 at 21:36, 10 hours 9 minutes ago

    EQS-Adhoc: Global Health Care AG: Board of Directors proposes sale of milon stake based on an equity value of EUR 23.3 million – subscription right for all shareholders

  • Published on 11/20/2026 at 19:26, 12 hours 20 minutes ago

    EQS-Adhoc: TAKKT AG: TAKKT revises its 2026 full-year forecast following the cyberattack

  • Published on 11/20/2026 at 19:03, 12 hours 42 minutes ago

    EQS-Adhoc: Allgeier SE confirms rumors regarding sale process for the Evora Group

View all EQS
Les Echos
  • Published on 11/20/2026 at 18:34, 13 hours 11 minutes ago

    Disclosure of transactions in own shares from November 16 to November 20, 2026

  • Published on 11/20/2026 at 17:35, 14 hours 11 minutes ago

    Guillemot Corporation S.A. | Weekly report share buyback from November 16 to November 20, 2026

  • Published on 11/19/2026 at 19:00, 1 day 12 hours ago

    MR.BRICOLAGE: OUTLOOK FOR THE 2026 FINANCIAL YEAR

  • Published on 11/19/2026 at 08:30, 1 day 23 hours ago

    Data sovereignty: Cegedim opens EB6, a next-generation datacenter for AI and high-density computing

  • Published on 11/19/2026 at 08:00, 1 day 23 hours ago

    EXOR TO RAISE ITS STAKE IN BIOMÉRIEUX

View all LES ECHOS COMFI WIRE

With finanzwire.com, you can follow all the latest financial news in real time from the best sources for companies listed on the Paris, Brussels, Amsterdam, Lisbon, Frankfurt and New York stock exchanges. You'll have access to summary articles written by us and press releases published by the companies themselves.

Finanzwire

87, rue Ordener - 75018 Paris

Contact us

+33 1 42 23 83 61

© 2026 Finanzwire

Contact Authors Cookies policy Terms and conditions Privacy policy